FFRangio System vs cV8 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FFRangio System

by CathWorks (acquired by Medtronic)

cV8 Diagnostic Ultrasound System

by Samsung Healthcare

AI Verdict

Tool A, the FFRangio System, is specifically designed for interventional cardiology, offering AI-driven, wire-free FFR guidance to optimize PCI decisions for coronary artery disease. In contrast, Tool B, the cV8 Diagnostic Ultrasound System, is a versatile diagnostic ultrasound platform leveraging AI for enhanced image quality and diagnostic assistance across multiple specialties, including fetal heart diagnosis. While both incorporate AI in cardiology, their primary modalities and specific clinical applications are distinct, catering to different stages of patient care and diagnostic needs.

Choose FFRangio System if…

Choose the FFRangio System if your cardiology department requires precise, non-invasive functional assessment of coronary artery disease to guide percutaneous coronary intervention (PCI) decisions. This system is ideal for optimizing and confirming PCI outcomes by providing real-time, wire-free FFR values and advanced insights into lesion impact and functional patterns of CAD directly within the cath lab.

View FFRangio System →

Choose cV8 Diagnostic Ultrasound System if…

Choose the cV8 Diagnostic Ultrasound System if your facility needs a versatile, premium mobile ultrasound solution offering superior image quality and AI-driven diagnostic assistance across a broad range of medical specialties. It is particularly well-suited for departments like obstetrics, gynecology, neurology, and radiology that benefit from advanced features such as fetal heart diagnosis, nerve detection, and quantitative tissue stiffness assessment to enhance diagnostic confidence and workflow.

View cV8 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FFRangio System	cV8 Diagnostic Ultrasound System
Pricing	Contact vendor for pricing information.	Varies
Deployment	SaaS, on-prem, hybrid	On-premise (hospital environments and outpatient diagnostic clinics)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FFRangio System

The FFRangio System is described as having an 'intuitive user interface' and 'seamless integration with cath lab boom and PACS', simplifying the operator experience. Clinicians have reported that the system is 'easy to use' and 'more user friendly' with product iterations, fitting seamlessly into workflow and saving time. This suggests a highly optimized user experience for its specific, complex procedural environment.

Clinical Value

FFRangio System

The FFRangio System offers significant clinical value by providing wire-free and drug-free FFR guidance, eliminating the need for invasive pressure wires and hyperemic agents. It has demonstrated excellent diagnostic accuracy of 93% in pooled analyses of multiple prospective studies and comparable one-year major adverse cardiac event (MACE) rates to invasive FFR. This reduces patient discomfort, potential complications, and radiation dose, while improving efficiency.

Pricing & Value

FFRangio System

While both tools require contacting the vendor for pricing, the FFRangio System has demonstrated significant economic advantages. Studies show a reduction in overall costs (approximately $374-$400 per patient) compared to invasive wire-based FFR, driven by reduced resource utilization and consumables. This tangible cost-saving potential, alongside improved patient outcomes and efficiency, indicates a strong value proposition.

Enterprise Readiness

cV8 Diagnostic Ultrasound System

Tool B (cV8 Diagnostic Ultrasound System) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) available, which are critical for healthcare enterprise readiness. Tool A (FFRangio System) states it is ISO 27001 certified for information security and FDA cleared, but its HIPAA compliance and BAA status are only 'likely' or 'unknown' based on the provided JSON. Explicit compliance is a stronger indicator for enterprise adoption.

Innovation

FFRangio System

The FFRangio System represents a significant innovation by providing wire-free and drug-free 3D FFR guidance, transforming how coronary artery disease is diagnosed and treated. This approach is a disruptive technology that changes the workflow in the cath lab, offering a less invasive and more efficient method for physiological assessment. While Tool B offers advanced AI in ultrasound, Tool A's innovation fundamentally alters a traditional invasive procedure.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offered specific details regarding the level of ongoing support, training programs, or comprehensive documentation available for either the FFRangio System or the cV8 Diagnostic Ultrasound System. Without this information, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FFRangio System	cV8 Diagnostic Ultrasound System
Name	FFRangio System	cV8 Diagnostic Ultrasound System
Company	CathWorks	Samsung Medison Co.
Description	The CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease.	The Samsung Medison cV8 Diagnostic Ultrasound System is a premium, mobile, and software-controlled ultrasound system featuring advanced Crystal Architectureu2122 for superior image quality and AI-based diagnostic assistance tools like NerveTracku2122 and HeartAssistu2122 to enhance clinical confidence and workflow efficiency across diverse medical specialties.
Categories	Cardiology AI, Surgical AI	Cardiology AI, Radiology & Imaging AI
Specialties	Cardiology	Neurology, Obstetrics & Gynecology, Radiology
Key Features (Examples)	Real-time FFRangio values at every point on the coronary tree, Simulated pullback curve differentiates functional patterns of CAD, Lesion Impact feature to assess residual ischemia	Crystal Architectureu2122 (CrystalBeamu2122, CrystalLiveu2122, S-Vue Single Crystal Transducersu2122) for superior image clarity and penetration, AI-based Intelligent Assist solutions: NerveTracku2122 (nerve detection), UterineAssistu2122 (uterus measurement), BiometryAssistu2122 (fetal growth)

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and cV8 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each system integrate into existing clinical workflows for their respective specialties, and what specific clinical scenarios are they designed to optimize?

The FFRangio System is specifically designed for interventional cardiology, seamlessly integrating with cath lab equipment and PACS to provide wire-free and drug-free FFR guidance for optimizing PCI decisions and assessing residual ischemia. The cV8 Diagnostic Ultrasound System is a versatile, mobile ultrasound that enhances workflows across neurology, OB/GYN, and radiology with AI-based tools like NerveTracku2122 and HeartAssistu2122 for real-time diagnostics and fetal heart diagnosis.

What is the depth of EHR integration for each system, particularly regarding automated data transfer or structured reporting?

The FFRangio System offers seamless integration with PACS, facilitating efficient image and data transfer within the cardiology workflow. The cV8 Diagnostic Ultrasound System, as a diagnostic imaging device, would primarily integrate for image archiving, structured reporting, and potentially automated measurements directly into the patient's record, streamlining documentation and access to diagnostic findings.

What clinical evidence supports the accuracy and sensitivity of the AI-driven diagnostic assistance and quantitative measurements provided by each system?

The CathWorks FFRangio System has demonstrated high diagnostic accuracy, sensitivity, and specificity (e.g., 93% diagnostic accuracy in a pooled analysis of five prospective studies) when compared to invasive FFR wires, promising to increase physiologic coronary lesion assessment. The cV8 Diagnostic Ultrasound System leverages Crystal Architecture for superior image quality and AI tools like NerveTracku2122 and HeartAssistu2122 to enhance diagnostic confidence, though specific sensitivity metrics for its AI features would require further clinical data.

What is the typical learning curve for physicians and staff to achieve proficiency with each system, and what is the expected time-to-value for realizing clinical and operational benefits?

The FFRangio System features an intuitive user interface and AI for quick angiogram analysis, with studies suggesting a short learning curve (e.g., 5 cases) to achieve proficiency and rapid time-to-value by streamlining PCI decision-making. The cV8 Diagnostic Ultrasound System includes EzExam+u2122 and EzPrepu2122 for streamlined examination protocols, which aims to facilitate faster staff adoption and quicker realization of workflow efficiencies across its diverse applications.

What specific information security certifications or measures, beyond standard regulatory compliance, does each system employ to protect patient data and ensure system integrity?

The FFRangio System is ISO 27001 certified for information security, indicating a robust framework for managing information security risks. The cV8 Diagnostic Ultrasound System, while HIPAA compliant, also adheres to Samsung's comprehensive cybersecurity solution, which focuses on intrusion prevention, access control, and data protection, and complies with quality system regulations like ISO 13485.

What are the key considerations for implementing and standardizing the use of each system across multiple hospital sites or a large healthcare network?

For the FFRangio System, multi-site rollout involves integrating with existing cath lab equipment and PACS at each location, requiring standardization of interventional cardiology workflows and training. The mobile cV8 Diagnostic Ultrasound System offers flexibility in deployment across different departments or sites, but would necessitate consistent training and protocol adherence for its diverse AI-assisted applications and integration with other imaging modalities via S-Fusionu2122.

What resources are available for prospective customers to evaluate real-world performance and user satisfaction, and what is the typical level of post-implementation support provided?

Prospective customers can typically evaluate real-world performance through customer testimonials, clinical studies, and potentially by contacting existing users to understand their experiences with the systems. Post-implementation support for medical devices generally includes technical assistance, software updates, and ongoing clinical training to ensure optimal system utilization and sustained performance.